Retrospective evaluation of Dysport™ and BOTOX drug utilization in the management of patients with cervical dystonia or blepharospasm

被引：0

作者：

Magar, R

Marchetti, A

Ahmed, F

Ferguson, I

机构：

[1] Thomson Phys World, Secaucus, NJ USA

[2] Hull Royal Infirm, Kingston Upon Hull HU3 2JZ, N Humberside, England

[3] Frenchay Hosp, Bristol BS16 1LE, Avon, England

来源：

VALUE IN HEALTH | 2002年 / 5卷 / 06期

关键词：

D O I：

10.1016/S1098-3015(10)61354-X

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：510 / 510

页数：1

共 50 条

[41] COST-UTILITY ANALYSIS OF TWO TYPE-A BOTULINUM TOXINS IN THE MANAGEMENT OF BLEPHAROSPASM AND CERVICAL DYSTONIA IN SPAIN
Sanz-Granda, A.
VALUE IN HEALTH, 2016, 19 (07) : A433 - A433
[42] XCiDaBLE: A phase 4, observational, prospective trial evaluating incobotulinumtoxinA for cervical dystonia or blepharospasm in the United States - Preliminary baseline results for patients with blepharospasm
LeDoux, M. S.
Jankovic, J. J.
Sethi, K.
Verma, A.
Pappert, E. J.
Fernandez, H. H.
MOVEMENT DISORDERS, 2012, 27 : S348 - S349
[43] Evaluation of outcome of different neurosurgical modalities in management of cervical dystonia
Alkarras, Mazen
Nabeeh, Adel
El Molla, Shafik
El Gayar, Abdelrahman
Fayed, Zeiad Y.
Ghany, Walid Abdel
Raslan, Ahmed M.
EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2022, 58 (01):
[44] Evaluation of outcome of different neurosurgical modalities in management of cervical dystonia
Mazen Alkarras
Adel Nabeeh
Shafik El Molla
Abdelrahman El Gayar
Zeiad Y. Fayed
Walid Abdel Ghany
Ahmed M. Raslan
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 58
[45] Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical Dystonia
Tilden, Dominic
Guarnieri, Carmel
VALUE IN HEALTH, 2016, 19 (02) : 145 - 152
[46] COST-EFFECTIVENESS OF INCOBOTULINUMTOXIN-A WITH FLEXIBLE TREATMENT INTERVALS COMPARED TO ONABOTULINUMTOXIN-A IN THE MANAGEMENT OF BLEPHAROSPASM AND CERVICAL DYSTONIA
Tilden, D.
Guarnieri, C.
Jackson, D.
VALUE IN HEALTH, 2015, 18 (07) : A759 - A759
[47] Health care resource utilization and costs among patients with spasticity or cervical dystonia
Hull, Michael
Danchenko, Natalya
Anupindi, Vamshi Ruthwik
DeKoven, Mitchell
He, Jing
Bouchard, Jonathan
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (01): : 86 - 97
[48] CD-PROBE (Cervical Dystonia Patient Registry for Observation of BOTOX® Efficacy) - A Multicenter, Observational Study of Repeated OnabotulinumtoxinA Injections in Cervical Dystonia (CD) Patients - Preliminary Baseline Data
Jankovic, Joseph
Adler, Charles
Charles, David
Comella, Cynthia
Stacy, Mark
Kurth, Matthias
Brin, Mitchell
Misell, Lisa
Boo, Lee M.
NEUROLOGY, 2010, 74 (09) : A85 - A86
[49] Cost-utility analysis of flexible interval incobotulinumtoxinA versus onabotulinumtoxinA in the management of blepharospasm and cervical dystonia in Ontario, Canada.
Gendron, M. E.
Gendron, M. E.
Kazerooni, R.
MOVEMENT DISORDERS, 2017, 32
[50] COST-EFFECTIVENESS OF INCOBOTULINUMTOXIN-A WITH FLEXIBLE TREATMENT INTERVALS COMPARED TO FIXED TREATMENT INTERVALS IN THE MANAGEMENT OF BLEPHAROSPASM AND CERVICAL DYSTONIA
Tilden, D.
Guarnieri, C.
VALUE IN HEALTH, 2016, 19 (07) : A433 - A433

← 1 2 3 4 5 →